302 related articles for article (PubMed ID: 28174211)
1. Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts.
Schuetze KB; Stratton MS; Blakeslee WW; Wempe MF; Wagner FF; Holson EB; Kuo YM; Andrews AJ; Gilbert TM; Hooker JM; McKinsey TA
J Pharmacol Exp Ther; 2017 Apr; 361(1):140-150. PubMed ID: 28174211
[TBL] [Abstract][Full Text] [Related]
2. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
[TBL] [Abstract][Full Text] [Related]
3. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
Khan N; Jeffers M; Kumar S; Hackett C; Boldog F; Khramtsov N; Qian X; Mills E; Berghs SC; Carey N; Finn PW; Collins LS; Tumber A; Ritchie JW; Jensen PB; Lichenstein HS; Sehested M
Biochem J; 2008 Jan; 409(2):581-9. PubMed ID: 17868033
[TBL] [Abstract][Full Text] [Related]
4. HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury.
Herr DJ; Baarine M; Aune SE; Li X; Ball LE; Lemasters JJ; Beeson CC; Chou JC; Menick DR
J Mol Cell Cardiol; 2018 Jan; 114():309-319. PubMed ID: 29224834
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA
Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565
[TBL] [Abstract][Full Text] [Related]
6. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
[TBL] [Abstract][Full Text] [Related]
7. Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide.
Chang J; Varghese DS; Gillam MC; Peyton M; Modi B; Schiltz RL; Girard L; Martinez ED
Br J Cancer; 2012 Jan; 106(1):116-25. PubMed ID: 22158273
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins.
Pang M; Ma L; Liu N; Ponnusamy M; Zhao TC; Yan H; Zhuang S
J Cell Biochem; 2011 Aug; 112(8):2138-48. PubMed ID: 21465537
[TBL] [Abstract][Full Text] [Related]
9. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury.
Marumo T; Hishikawa K; Yoshikawa M; Hirahashi J; Kawachi S; Fujita T
Am J Physiol Renal Physiol; 2010 Jan; 298(1):F133-41. PubMed ID: 19906951
[TBL] [Abstract][Full Text] [Related]
11. Class I HDAC inhibition stimulates cardiac protein SUMOylation through a post-translational mechanism.
Blakeslee WW; Wysoczynski CL; Fritz KS; Nyborg JK; Churchill ME; McKinsey TA
Cell Signal; 2014 Dec; 26(12):2912-20. PubMed ID: 25220405
[TBL] [Abstract][Full Text] [Related]
12. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
[TBL] [Abstract][Full Text] [Related]
14. Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.
Williams SM; Golden-Mason L; Ferguson BS; Schuetze KB; Cavasin MA; Demos-Davies K; Yeager ME; Stenmark KR; McKinsey TA
J Mol Cell Cardiol; 2014 Feb; 67():112-25. PubMed ID: 24374140
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Histone Deacetylases Induces K+ Channel Remodeling and Action Potential Prolongation in HL-1 Atrial Cardiomyocytes.
Lugenbiel P; Govorov K; Rahm AK; Wieder T; Gramlich D; Syren P; Weiberg N; Seyler C; Katus HA; Thomas D
Cell Physiol Biochem; 2018; 49(1):65-77. PubMed ID: 30134221
[TBL] [Abstract][Full Text] [Related]
16. Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension.
Lemon DD; Horn TR; Cavasin MA; Jeong MY; Haubold KW; Long CS; Irwin DC; McCune SA; Chung E; Leinwand LA; McKinsey TA
J Mol Cell Cardiol; 2011 Jul; 51(1):41-50. PubMed ID: 21539845
[TBL] [Abstract][Full Text] [Related]
17. Natural indoles, indole-3-carbinol and 3,3'-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression.
Busbee PB; Nagarkatti M; Nagarkatti PS
Toxicol Appl Pharmacol; 2014 Jan; 274(1):7-16. PubMed ID: 24200994
[TBL] [Abstract][Full Text] [Related]
18. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.
Kong Y; Tannous P; Lu G; Berenji K; Rothermel BA; Olson EN; Hill JA
Circulation; 2006 Jun; 113(22):2579-88. PubMed ID: 16735673
[TBL] [Abstract][Full Text] [Related]
19. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.
Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886
[TBL] [Abstract][Full Text] [Related]
20. Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies.
Brindisi M; Cavella C; Brogi S; Nebbioso A; Senger J; Maramai S; Ciotta A; Iside C; Butini S; Lamponi S; Novellino E; Altucci L; Jung M; Campiani G; Gemma S
Future Med Chem; 2016 Sep; 8(13):1573-87. PubMed ID: 27556815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]